Follow-up of patients with hunter syndrome: The Hunter Outcome Survey (HOS) registry;Seguimiento de pacientes con síndrome de Hunter: El registro HOS (Hunter Outcome Survey)

Revista de Neurologia

Volumn 44, Issue SUPPL. 1, 2007, Pages

  Del Toro Riera, Mireia ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Enzyme replacement therapy; HOS registry; Hunter Outcome Survey; Hunter syndrome; Idursulfase; Mucopolysaccharidosis II

Indexed keywords

IDURONATE 2 SULFATASE;

CLINICAL FEATURE; DISEASE COURSE; DRUG SAFETY; ENZYME REPLACEMENT; FOLLOW UP; HUMAN; HUNTER SYNDROME; OBSERVATIONAL STUDY; PREVALENCE; REGISTER; REVIEW; X CHROMOSOME LINKED DISORDER; ADOLESCENT; ADULT; ARTICLE; CHILD; MALE; PRESCHOOL CHILD; SPAIN;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HUMANS; MALE; MUCOPOLYSACCHARIDOSIS II; REGISTRIES; SPAIN;

EID: 37549039029     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (6)

1. Neufeld EF, Muenzer J. The mucopolysaccharidosis. In Scriver CR, Beandet AL, Sly S, Valle D, Childs B, Kinzler KW, et al, eds. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill; 2001. p. 3421-52.
2. Tuschl K, Gal A, Paschke E, Kircher S, Bodamer OA. Mucopolysaccharidosis type II in females: case report and review of literature. Pediatr Neurol 2005; 32: 270-2.
3. Mc Kusick VA. Relative frequency of Hurler and Hunter syndromes. N Engl J Med 1970; 283: 1466-8.
4. Young ID, Harper PS. Incidence of Hunter's syndrome. Hum Genet 1982; 60: 391-2.
5. Muenzer J, Wraith JE, Beck M, Giugliani R, Armatz P, Eng CM, et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med 2006; 8: 465-73.
6. Muenzer J, Gucsavas-Calikoglu M, McCandless SE, Schuetz TJ, Kimura A. A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Mol Genet Metab 2006 [in press].